Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A fluorogenic assay for endothelin-converting enzyme.

T W von Geldern1, W H Holleman, T J Opgenorth

  • 1Cardiovascular Research Division, Abbott Laboratories, Abbott Park, IL 60064.

Peptide Research
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.

British journal of pharmacology·2007
Same author

Effect of ABT-627 (A-147627), a potent selective ET(A) receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia.

British journal of pharmacology·2001
Same author

Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 4. Structure-activity relationship of substituents on the benzene ring of the cinnamide.

Journal of medicinal chemistry·2001
Same author

New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models.

Journal of medicinal chemistry·2001
Same author

Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonists.

Journal of medicinal chemistry·2001
Same author

Discovery of potent antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 3. Amide (C-ring) structure-activity relationship and improvement of overall properties of arylthio cinnamides.

Journal of medicinal chemistry·2001
Same journal

Solution structure of vasoactive intestinal polypeptide (11-28)-NH2, a fragment with analgesic properties.

Peptide research·1996
Same journal

NMR study of five N-terminal peptide fragments of the vasoactive intestinal peptide: crucial role of aromatic residues.

Peptide research·1996
Same journal

Crystallographic characterization of tryptophan-containing peptide 3(10)-helices.

Peptide research·1996
Same journal

Assignment of the disulfide bonds in napin, a seed storage protein from Brassica napus, using matrix-assisted laser desorption ionization mass spectrometry.

Peptide research·1996
Same journal

Effective use of free thiols as scavengers for HF cocktails to deprotect bromo- and chloroacetylated synthetic peptides.

Peptide research·1996
Same journal

Large-pore polydimethylacrylamide resin for solid-phase peptide synthesis: applications in Fmoc chemistry.

Peptide research·1996
See all related articles

Researchers developed a novel fluorescence assay to detect endothelin-converting enzyme activity. This assay aids in identifying enzymes that process big endothelin into the potent vasoconstrictor endothelin-1.

Area of Science:

  • Biochemistry
  • Enzymology
  • Molecular Biology

Background:

  • Endothelin-1 is a potent vasoconstrictor peptide.
  • Endothelin-1 is produced from a precursor, big endothelin, through proteolysis.
  • Identifying the specific endothelin-converting enzyme is crucial for understanding its biological role.

Purpose of the Study:

  • To develop a novel assay for detecting endothelin-converting enzyme activity.
  • To facilitate the identification of the enzyme responsible for big endothelin cleavage.
  • To provide a tool for studying endothelin-1 biosynthesis.

Main Methods:

  • Development of a synthetic peptide substrate incorporating a dansyl fluorophore and a tryptophan residue.
  • Utilizing intramolecular fluorescence energy transfer (FRET) for signal detection.

Related Experiment Videos

  • Validation of the assay using chymotrypsin as a model protease.

    • Main Results:

    • The assay demonstrates a measurable increase in fluorescence upon cleavage of the synthetic substrate.
    • The assay successfully detected novel endothelin-converting enzyme activities.
    • Chymotrypsin was used to validate the assay's efficacy in mimicking protease activity.

    Conclusions:

    • A novel FRET-based assay has been successfully developed and validated for endothelin-converting enzyme activity.
    • This assay is a valuable tool for the discovery and characterization of endothelin-converting enzymes.
    • The assay facilitates research into the biosynthesis of endothelin-1 and its physiological roles.